CellaVision AB (C26.F)

Every figure this model derived for C26.F, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 11,994,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 149,430,000 CashAndCashEquivalents 2025-01-01
current assets 402,813,000 CurrentAssets 2025-01-01
current liabilities 109,110,000 CurrentLiabilities 2025-01-01
equity 815,727,000 EquityAttributableToOwnersOfParent 2025-01-01
ocf 198,438,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 723,217,000 Revenue 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up C26.F on one particular measure came for.

RatioValue
cash operating margin24.57
current ratio3.69
current ratio reported3.69
fcf margin25.78
operating margin24.57
owner earnings margin25.78
revenue growth6.78
revenue growth per share6.78
roic20.67
rule of 4031.35
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about C26.F's figures. Written by the derivation as it ran, not added afterwards.